Altria (MO) filed its fiscal year 2024 10-K annual report with the SEC on Feb 26, 2025. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.
AI Filing AnalysisFY2024 10-K
Business Overview
- • Core business: Leadership in U.S. tobacco industry with strategic focus on smoke-free and innovative nicotine products
- • Emphasis on U.S. smoke-free portfolio: target 35% volume growth from 800M units in 2022, aiming to double net revenues to $5B by 2028
Management Discussion & Analysis
- • Revenue performance and YoY change not disclosed in provided text
- • No specific profitability, margin, or operating margin figures included
Risk Factors
- • Legal risk from IRS agreement on $6.4B ordinary loss relating to JUUL investment tax treatment in October 2024
- • Operational risk from contingent NJOY payments totaling $250 million impacting cash flows in 2023-2024
Financial SummaryXBRL
Revenue
$24.0B
Net Income
$11.3B
Gross Margin
59.8%
Operating Margin
46.8%
Net Margin
46.9%
ROE
-503.3%
Total Assets
$35.2B
EPS (Diluted)
$6.54
Operating Cash Flow
$8.8B
Source: XBRL data from Altria FY2024 10-K filing on SEC EDGAR. All figures in USD.
Other Altria Annual Reports
Get deeper insights on Altria
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.